Envíos recientes

Acute effects of butyrate on intestinal permeability in patients with irritable bowel syndrome assessed by a novel colonoscopy research model

Scharf, Mathias Wolfgang; Forsgård, Richard; Prado, Samira; Ganda Mall, John-Peter; Repsilber, Dirk; Brummer, Robert (Taylor & Francis, 2025)

First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study

San Román, Luis; Pich, Sara; Domingo Rodriguez, Laura; Duran, Marta; Duocastella, Lluís; Gramegna, Laura Ludovica (Frontiers Media, 2025-03-05)

Tratamiento de la crisis epiléptica en el ámbito no sanitario: tiempo de tratar (TT)

García Morales, Irene; Soto Insuga, Víctor; SERRANO-CASTRO, PEDRO J; Toledo, Manuel; Serratosa, Jose; Carreno Martinez, Maria del Mar (Elsevier, 2025-08)

Autoantibodies are associated with worse outcomes in MASLD

Soria, Anna; IRUZUBIETA, PAULA; Martin-Mateos, Rosa; Jiménez, Alba; Calixto, Zyanya; Sabiote Cartes, Clara; Díaz, Alba; Salcedo, Maria-Teresa; Pericas, Juan M; muñoz, sergio (Elsevier, 2025-10)

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer

He, Jianxing; Tsuboi, Masahiro; Weder, Walter; Chen, Keneng; Hochmair, Maximilian; Shih, Jin-Yuan; MARTINEZ-MARTI, ALEX (American Society of Clinical Oncology, 2025-09-10)

Scientia. Depósito de Información Digital del Departamento de Salud

Institut Català de la Salut - ICS: Envíos recientes

Acute effects of butyrate on intestinal permeability in patients with irritable bowel syndrome assessed by a novel colonoscopy research model

First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study

Tratamiento de la crisis epiléptica en el ámbito no sanitario: tiempo de tratar (TT)

Autoantibodies are associated with worse outcomes in MASLD

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer

Scientia. Depósito de Información Digital del Departamento de Salud

Institut Català de la Salut - ICS: Envíos recientes

Acute effects of butyrate on intestinal permeability in patients with irritable bowel syndrome assessed by a novel colonoscopy research model ﻿

First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study ﻿

Tratamiento de la crisis epiléptica en el ámbito no sanitario: tiempo de tratar (TT) ﻿

Autoantibodies are associated with worse outcomes in MASLD ﻿

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer ﻿

Acute effects of butyrate on intestinal permeability in patients with irritable bowel syndrome assessed by a novel colonoscopy research model

First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study

Tratamiento de la crisis epiléptica en el ámbito no sanitario: tiempo de tratar (TT)

Autoantibodies are associated with worse outcomes in MASLD

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer